Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blanke

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2013
NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelinesGeorge D Demetri, Robert Benjamin, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2022
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment StudiesJoseph M Unger, Michael LeBlanc, Suzanne George, et al.
Cancer|April 21, 2021
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohortSandip Pravin Patel, Edward Mayerson, Young Kwang Chae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2017
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518James C Yao, Katherine A Guthrie, Cesar Moran, et al.
Cancer|February 15, 2024
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancerSandip P Patel, Elizabeth Guadarrama, Young Kwang Chae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2019
Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)Heinz-Josef Lenz, Fang-Shu Ou, Alan P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resectionStephen R Smalley, Jacqueline K Benedetti, Daniel G Haller, et al.
Cancer|August 31, 2023
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)Justin C Brown, Chao Ma, Qian Shi, et al.
The Oncologist|January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancerRichard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancerCarol M Moinpour, Nancy L Vaught, Bryan Goldman, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2013
NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelinesGeorge D Demetri, Robert Benjamin, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2022
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment StudiesJoseph M Unger, Michael LeBlanc, Suzanne George, et al.
Cancer|April 21, 2021
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohortSandip Pravin Patel, Edward Mayerson, Young Kwang Chae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2017
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518James C Yao, Katherine A Guthrie, Cesar Moran, et al.
Cancer|February 15, 2024
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancerSandip P Patel, Elizabeth Guadarrama, Young Kwang Chae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2019
Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)Heinz-Josef Lenz, Fang-Shu Ou, Alan P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resectionStephen R Smalley, Jacqueline K Benedetti, Daniel G Haller, et al.
Cancer|August 31, 2023
Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)Justin C Brown, Chao Ma, Qian Shi, et al.
The Oncologist|January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancerRichard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancerCarol M Moinpour, Nancy L Vaught, Bryan Goldman, et al.
Pageof 19